Ensign Peak Advisors
SWTX

Ensign Peak Advisors’s SpringWorks Therapeutics SWTX Stock Holding History

Ensign Peak Advisors’s Portfolio SWTX Stock Details SWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-19,241
Closed -$849K – 1719
2025
Q1 		$849K Buy
19,241
+200
+1% +$9.21K ﹤0.01% 1338
2024
Q4 		$688K Sell
19,041
-145,903
-88% -$5.1M ﹤0.01% 1505
2024
Q3 		$5.28M Buy
164,944
+200
+0.1% +$7.47K 0.01% 610
2024
Q2 		$6.21M Buy
164,744
+62,953
+62% +$2.65M 0.01% 573
2024
Q1 		$5.01M Buy
101,791
+81,791
+409% +$3.78M 0.01% 630
2023
Q4 		$730K Buy
+20,000
New +$522K ﹤0.01% 1542
2022
Q4 		– Sell
-5,220
Closed -$149K – 2176
2022
Q3 		$149K Sell
5,220
-70,499
-93% -$2.02M ﹤0.01% 1980
2022
Q2 		$1.86M Sell
75,719
-38,471
-34% -$1.41M ﹤0.01% 828
2022
Q1 		$6.45M Buy
114,190
+11,410
+11% +$653K 0.01% 521
2021
Q4 		$6.37M Buy
102,780
+20,619
+25% +$1.36M 0.01% 595
2021
Q3 		$5.21M Buy
82,161
+17,527
+27% +$1.35M 0.01% 645
2021
Q2 		$5.33M Buy
64,634
+20,408
+46% +$1.55M 0.01% 630
2021
Q1 		$3.25M Buy
44,226
+18,200
+70% +$1.43M 0.01% 822
2020
Q4 		$1.89M Hold
26,026
– – ﹤0.01% 1096
2020
Q3 		$1.24M Buy
26,026
+16,623
+177% +$708K ﹤0.01% 1213
2020
Q2 		$395K Hold
9,403
– – ﹤0.01% 1505
2020
Q1 		$254K Buy
+9,403
New +$307K ﹤0.01% 1503

Other funds holding SWTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

Ensign Peak Advisors's SWTX Position: Q2 2025 in Review

Ensign Peak Advisors sold out of SpringWorks Therapeutics (SWTX) in Q2 2025, closing a stake of 19,241 shares — an estimated $849K sold.

Ensign Peak Advisors first reported a position in SWTX in Q1 2020 and held it in 17 quarters. The position peaked at $6.45M in Q1 2022. 223 funds tracked by Wall St. Rank hold SWTX as of Q2 2025.

  • Ensign Peak Advisors reported no remaining SpringWorks Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Ensign Peak Advisors sold 19,241 SpringWorks Therapeutics shares in Q2 2025, an estimated $849K.
  • Ensign Peak Advisors first reported a position in SpringWorks Therapeutics in Q1 2020 and held it in 17 quarters.
  • Ensign Peak Advisors's SpringWorks Therapeutics position peaked at $6.45M in Q1 2022.
  • 223 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q2 2025.

Based on Ensign Peak Advisors's 13F filing for Q2 2025, filed 12 Aug 2025.